Los Angeles Capital Management
CSTL icon

Los Angeles Capital Management’s Castle Biosciences CSTL Stock Holding History

Los Angeles Capital Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312K Sell
12,728
-10,903
-46% -$357K ﹤0.01% 1011
2025
Q4 		$572K Sell
23,631
-490
-2% -$15.8K ﹤0.01% 839
2025
Q3 		$549K Buy
+24,121
New +$490K ﹤0.01% 909
2025
Q2 		– Sell
-33,970
Closed -$680K – 1365
2025
Q1 		$680K Buy
+33,970
New +$841K ﹤0.01% 672
2024
Q2 		– Sell
-18,201
Closed -$403K – 1189
2024
Q1 		$403K Hold
18,201
– – ﹤0.01% 930
2023
Q4 		$393K Sell
18,201
-2,984
-14% -$52.5K ﹤0.01% 939
2023
Q3 		$358K Buy
+21,185
New +$371K ﹤0.01% 913
2023
Q2 		– Sell
-20,863
Closed -$474K – 1189
2023
Q1 		$474K Sell
20,863
-773
-4% -$18.9K ﹤0.01% 869
2022
Q4 		$509K Sell
21,636
-229
-1% -$5.31K ﹤0.01% 898
2022
Q3 		$570K Hold
21,865
– – ﹤0.01% 880
2022
Q2 		$480K Buy
+21,865
New +$508K ﹤0.01% 981
2021
Q4 		– Sell
-3,282
Closed -$218K – 1412
2021
Q3 		$218K Hold
3,282
– – ﹤0.01% 1403
2021
Q2 		$241K Sell
3,282
-27,496
-89% -$1.82M ﹤0.01% 1449
2021
Q1 		$2.11M Sell
30,778
-20,453
-40% -$1.54M 0.01% 604
2020
Q4 		$3.44M Buy
51,231
+3,945
+8% +$214K 0.01% 491
2020
Q3 		$2.43M Buy
47,286
+20,404
+76% +$908K 0.01% 517
2020
Q2 		$1.01M Buy
26,882
+6,056
+29% +$207K ﹤0.01% 842
2020
Q1 		$621K Buy
+20,826
New +$628K ﹤0.01% 841

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Los Angeles Capital Management's CSTL Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Castle Biosciences (CSTL) stake by 46% in Q1 2026, selling an estimated $357K and leaving 12,728 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Los Angeles Capital Management first reported a position in CSTL in Q1 2020 and has held it in 18 quarters since. The position peaked at $3.44M in Q4 2020. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Los Angeles Capital Management held 12,728 shares of Castle Biosciences worth $312K as of Q1 2026.
  • Los Angeles Capital Management sold 10,903 Castle Biosciences shares in Q1 2026, an estimated $357K.
  • Castle Biosciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1011 holding.
  • Los Angeles Capital Management first reported a position in Castle Biosciences in Q1 2020 and has held it in 18 quarters since.
  • Los Angeles Capital Management's Castle Biosciences position peaked at $3.44M in Q4 2020.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.